JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C200230200 on May 24, 2002

J. Biol. Chem., Vol. 277, Issue 28, 24859-24862, July 12, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/28/24859    most recent
C200230200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giannì, M.
Right arrow Articles by Rochette-Egly, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giannì, M.
Right arrow Articles by Rochette-Egly, C.

ACCELERATED PUBLICATION
Down-regulation of the Phosphatidylinositol 3-Kinase/Akt Pathway Is Involved in Retinoic Acid-induced Phosphorylation, Degradation, and Transcriptional Activity of Retinoic Acid Receptor gamma 2*

Maurizio GiannìDagger , Eliezer Kopf§, Julie Bastien, Mustapha Oulad-Abdelghani, Enrico Garattini||, Pierre Chambon, and Cécile Rochette-Egly**

From the Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université Louis Pasteur/Collège de France, BP 163, 67404 Illkirch Cedex, France and || Laboratorio di Biologia Molecolare, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italia

Nuclear retinoic acid (RA) receptors (RARs) are phosphorylated at conserved serine residues located in their N-terminal domain. Phosphorylation of RARgamma 2 at these residues is increased in response to RA subsequently to the activation of p38MAPK. We show here that this RA-induced phosphorylation of RARgamma 2 resulted from the down-regulation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. By overexpressing Akt and by using agents that activated or inhibited the PI3K/Akt pathway, we also demonstrated that the RA-induced down-regulation of the PI3K/Akt pathway targeted not only the phosphorylation of RARgamma 2 but also the turnover and transcriptional activity of the receptor. Altogether these data indicate that the PI3K/Akt pathway plays an important role in retinoic acid signaling.


* This work was supported by funds from the CNRS, the INSERM, the Collège de France, the Hôpital Universitaire de Strasbourg, the Association pour la Recherche sur le Cancer, and Bristol-Myers Squibb.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported by short term fellowships from the Human Frontier Science Program, by the Association pour la Recherche sur le Cancer, and by FIRC (Fondazione Italiana per la Ricerca sul Cancro). Present address: Laboratorio di Biologia Molecolare, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italia.

§ Supported by Fondation Chateaubriand and by an INSERM fellowship. Present address: Sigma Israël, Plaut 3, Park-Rabin, Rehovot, Israël 76100.

Supported by the Ministère de la Recherche et de l'Enseignement Supérieur.

** To whom correspondence should be addressed: Institut de Génétique et de Biologie Moléculaire et Cellulaire, BP 163, 67404 Illkirch Cedex, Communauté Urbaine de Strasbourg, France. Tel.: 33-3-88-65-34-59; Fax: 33-3-88-65-32-01; E-mail: cegly@igbmc.u-strasbg.fr.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. Nakanishi, Y. Tomaru, H. Miura, Y. Hayashizaki, and M. Suzuki
Identification of transcriptional regulatory cascades in retinoic acid-induced growth arrest of HepG2 cells
Nucleic Acids Res., April 29, 2008; (2008) gkn066v1.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B. Ozpolat, U. Akar, M. Steiner, I. Zorrilla-Calancha, M. Tirado-Gomez, N. Colburn, M. Danilenko, S. Kornblau, and G. Lopez Berestein
Programmed Cell Death-4 Tumor Suppressor Protein Contributes to Retinoic Acid-Induced Terminal Granulocytic Differentiation of Human Myeloid Leukemia Cells
Mol. Cancer Res., January 1, 2007; 5(1): 95 - 108.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer
International Union of Pharmacology. LX. Retinoic Acid Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 712 - 725.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. M. Day, Y. H. Lee, A.-M. Park, and Y. J. Suzuki
Retinoic Acid Inhibits Airway Smooth Muscle Cell Migration
Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 695 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Bour, J.-L. Plassat, A. Bauer, S. Lalevee, and C. Rochette-Egly
Vinexin {beta} Interacts with the Non-phosphorylated AF-1 Domain of Retinoid Receptor {gamma} (RAR{gamma}) and Represses RAR{gamma}-mediated Transcription
J. Biol. Chem., April 29, 2005; 280(17): 17027 - 17037.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
D. Pasquali, P. Chieffi, W. J Deery, G. Nicoletti, A. Bellastella, and A. A Sinisi
Differential effects of all-trans-retinoic acid (RA) on Erk1/2 phosphorylation and cAMP accumulation in normal and malignant human prostate epithelial cells: Erk1/2 inhibition restores RA-induced decrease of cell growth in malignant prostate cells
Eur. J. Endocrinol., April 1, 2005; 152(4): 663 - 669.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. D. Licht and A. Zelent
Retinoid and growth factor receptor signaling in APL
Blood, February 15, 2005; 105(4): 1381 - 1382.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Parrella, M. Gianni', V. Cecconi, E. Nigro, M. M. Barzago, A. Rambaldi, C. Rochette-Egly, M. Terao, and E. Garattini
Phosphodiesterase IV Inhibition by Piclamilast Potentiates the Cytodifferentiating Action of Retinoids in Myeloid Leukemia Cells: CROSS-TALK BETWEEN THE cAMP AND THE RETINOIC ACID SIGNALING PATHWAYS
J. Biol. Chem., October 1, 2004; 279(40): 42026 - 42040.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Garattini, E. Parrella, L. Diomede, M. Gianni', Y. Kalac, L. Merlini, D. Simoni, R. Zanier, F. F. Ferrara, I. Chiarucci, et al.
ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis
Blood, January 1, 2004; 103(1): 194 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Brouillard and C. E. Cremisi
Concomitant Increase of Histone Acetyltransferase Activity and Degradation of p300 during Retinoic Acid-induced Differentiation of F9 Cells
J. Biol. Chem., October 10, 2003; 278(41): 39509 - 39516.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Gianni, A. Tarrade, E. A. Nigro, E. Garattini, and C. Rochette-Egly
The AF-1 and AF-2 Domains of RAR{gamma}2 and RXR{alpha} Cooperate for Triggering the Transactivation and the Degradation of RAR{gamma}2/RXR{alpha} Heterodimers
J. Biol. Chem., September 5, 2003; 278(36): 34458 - 34466.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kambhampati, Y. Li, A. Verma, A. Sassano, B. Majchrzak, D. K. Deb, S. Parmar, N. Giafis, D. V. Kalvakolanu, A. Rahman, et al.
Activation of Protein Kinase C{delta} by All-trans-retinoic Acid
J. Biol. Chem., August 29, 2003; 278(35): 32544 - 32551.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Matsushima-Nishiwaki, M. Okuno, Y. Takano, S. Kojima, S. L. Friedman, and H. Moriwaki
Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid
Carcinogenesis, August 1, 2003; 24(8): 1353 - 1359.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Launay, M. Gianni, L. Diomede, L. M. Machesky, J. Enouf, and B. Papp
Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum: cross-talk between RARalpha and calcium-dependent signaling
Blood, April 15, 2003; 101(8): 3220 - 3228.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. B. Goodman and A. B. Pardee
Evidence for defective retinoid transport and function in late onset Alzheimer's disease
PNAS, March 4, 2003; 100(5): 2901 - 2905.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.